Haldor Topsoe Holding A/S 4
4 · IGM Biosciences, Inc. · Filed Sep 20, 2019
Insider Transaction Report
Form 4
Topsoe Holding A/S
10% Owner
Transactions
- Conversion
Series B Preferred Stock
2019-09-20−9,039,453→ 0 total→ Common Stock (9,039,453 underlying) - Conversion
Series C Preferred Stock
2019-09-20−2,269,838→ 0 total→ Non-Voting Common Stock (2,269,838 underlying) - Purchase
Common Stock
2019-09-18$16.00/sh+1,250,000$20,000,000→ 1,250,000 total - Conversion
Common Stock
2019-09-20+9,039,453→ 10,289,453 total - Conversion
Non-Voting Common Stock
2019-09-20+2,269,838→ 2,269,838 total→ Common Stock (2,269,838 underlying)
Footnotes (3)
- [F1]All shares are held directly by Haldor Topsoe Holding A/S (HTH). Mr. Jakob Haldor Topsoe, Ms. Christina Teng Topsoe, Mr. Martin Topsoe and Mr. Emil Oigaard, members of the board of directors of HTH, may be deemed to share voting and investment power with respect to the shares reported herein and disclaim beneficial ownership of such shares, except to the extent of his or her pecuniary interest therein, if any. Mr. Jakob Haldor Topsoe and Ms. Christina Teng Topsoe are members of the Issuer's board of directors.
- [F2]The Series B Preferred Stock automatically converted into shares of Common Stock on a 1-for-1 basis immediately prior to the closing of the Issuer's initial public offering. The Series B Preferred Stock had no expiration date.
- [F3]The Series C Preferred Stock automatically converted into shares of Non-Voting Common Stock on a 1-for-1 basis, pursuant to an election made by the Reporting Person, immediately prior to the closing of the Issuer's initial public offering, and had no expiration date. Each share of Non-Voting Common Stock is convertible at any time at the option of the Reporting Person into one share of Common Stock (subject to a 4.99% beneficial ownership limitation that may be increased or decreased by the Reporting Person) and has no expiration date.